CIK 0001516551 · Non-accelerated filer<br>Smaller reporting company
Skye Bioscience, Inc.
Sign in to watch- Ticker
- SKYE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 450692882
- Phone
- (858) 410-0266
- Business address
- 11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
- Former names
- Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC., LOAD GUARD TRANSPORTATION, INC.
- 4/A Grant or award Chief Financial Officer acquired 25,000 shares (grant or award)
- 4/A Grant or award Chief Executive Officer acquired 100,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 25,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 100,000 shares (grant or award)
- 8-K Event Other events
- D Other Notice of Sales of Unregistered Securities
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Grant or award Director acquired 5,206,074 shares (grant or award)
- 4 Open-market buy 10% owner bought 5,206,074 shares at $2.31 ($12,026,031)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement · Agreement ended
- 10-Q Report Quarterly Report
- 8-K Event Bylaws or fiscal year change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 128,209 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 194,270 shares (grant or award)
Page 10 of 32 · 633 filings